28.06.2024 13:11:47 - dpa-AFX: *REGENERON: ODRONEXTAMAB RECOMMENDED FOR EU APPROVAL BY CHMP TO TREAT R/R FOLLICULAR LYMPHOMA AND DLBCL

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
REGENERON PHARMAC.DL-,001 881535 Frankfurt 990,800 12.07.24 11:29:33 +8,400 +0,85% 990,400 996,400 989,400 982,400

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH